News and Announcements
Ride-sharing service Scooti reached 2.13 billion online readership
- Published October 31, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Scooti is a ride-sharing mobile application that connects passengers wanting to get from point A to B. The company has received 2.13 billion online readership to date, since its launch.
CEO Brett Balsters opens up on their key advantage, stating “All our drivers are specially trained, insured and certified under government legislation.”
“We operate in and around the CBD where most roads are 40 km/hr zones, and helmets, hairnets and safety vests are provided to all our customers.”
Scooter taxi services already exist in several other countries around the world and they’re becoming increasingly popular in congested cities. In Singapore, there’s Grab, in Indonesia, there Go Jek, and in Italy, there’s Scooterino.
Scooti has expanded to Sydney and Melbourne and it operates daily from 5am to 10pm.
Check out Scooti’s You Tube channel here
Media coverage here
About Scooti
Scooti is a ride-sharing mobile application that connects passengers wanting to get from point A to B with the safest, most experienced, and reliable scooter drivers.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
